To view the full announcement, please refer to the PDF attached. ENQUEST PLC, 8 September 2016. Results for the 6 months ended 30 June 2016*. Strong production growth, 42,520 Boepd in H1 2016, up 43% on H1 2015 Unit opex down further to $23/bbl, ahead of target and now 50% down on H1 2014 Kraken on track for first oil in H1 2017, gross capex lowered by further c.$150m Continuing focus on strengthening the balance sheet * Unless otherwise stated, all figures are on a business performance basis and are in US dollars. Highlights · EnQuest is delivering against its strategic priorities in the continuing low oil price environment. Further action to reduce opex and capex has been accompanied by sustained strength in operations. High production efficiency has driven EnQuest’s highest H1 levels of production, with a well implemented drilling programme and with first oil from the Kraken development on schedule for H1 2017. · Production averaged 42,520 Boepd in H1 2016, strong growth of 43% on H1 2015, with production increases in every operated asset: · UK production grew by 22%, before inclusion of production from the new Alma/Galia development. Malaysian production was also up by over 20%. · Alma/Galia delivered an average net production of 6,433 Boepd in H1 2016. Post first oil optimisation of production levels has continued in H2 2016, including two well interventions and acid treatments. Following which, between 5 and 31 August gross Alma/Galia production averaged 18,785 Boepd. · With the extended period of production build up for Alma/Galia, full year 2016 production guidance is now anticipated to be in the range of between 42,000 and 44,000 Boepd, around the lower end of previous guidance, at the mid-point representing strong growth of c.18% over 2015. · Revenue of $391.3 million and EBITDA*** of $242.9 million, reflecting the strong operational performance. The $182.6 million of cash generated from operations was $99.3 million or 119% up on H1 2015, reflecting the production growth. · Continued further reductions in operating costs, H1 2016 unit opex was ahead of target at $23/bbl, benefiting from additional cost saving initiatives, including savings from EnQuest’s offshored procurement hub. Full year unit opex is now expected to be around the lower end of the $25-$27/bbl guidance; this reflects the impact of the Alma/Galia well interventions in H2. · 2016 EnQuest cash capex outflow is being reduced by a net c.$30 million, predominantly as a result of the further phasing of milestone payments. · The Kraken development is continuing on schedule. EnQuest today announces a further c.$150 million decrease in full cycle gross project capex, in addition to the c.$425 million of cost reductions announced since project sanction, giving a new gross full cycle project capex cost of c.$2.6 billion. Sail away of the Kraken FPSO is expected in H2 2016, as planned, ahead of first oil in H1 2017. In July 2016, EnQuest announced that it was conducting negotiations for the farm out of a 20% working interest in the exploration and production licences in the Kraken Field, to the Delek Group. EnQuest will provide further details in the event either of transaction documents being signed or of it becoming apparent that a binding agreement cannot be reached. · Scolty/Crathes is both ahead of schedule and under budget, with first oil now expected around the 2016 year end. · Net debt at the period end, was $1,681 million. Summary EnQuest CEO Amjad Bseisu: "Strong production of 42,520 Boepd has been delivered, representing broad based growth of 43% over H1 2015. Unit opex of $23/bbl is down 41% on the $39/bbl in H1 2015, and down 50% on the $46/bbl in H1 2014. 2016 cash capex, is reduced by a further c.$30 million, now set to be in the range between $670 million and $720 million. EnQuest is progressing both of its development projects ahead of budget; the Kraken FPSO is on track for sail away in H2 2016, with its full cycle gross capex costs now reduced by a further c.$150 million to c.$2.6 billion. The Scolty/Crathes development is ahead of schedule. This year’s drilling programme has been executed very efficiently, delivering more wells within the original budget. In H1 2016, EnQuest delivered EBITDA of $242.9 million and more than doubled cash generated from operations to $182.6 million, driven by the scale of the production growth, cost cutting and oil price hedging, more than countering the impact of lower oil prices. With very substantial structural reductions in our cost base already delivered, the long term potential of EnQuest’s business model remains compelling. EnQuest’s overriding priority continues to be delivering a business which is robust in this challenging environment."
Half-year Report To view the full announcement, please
Top 10 Most Recent News Articles
UBCF Extends Pink Bag Event for Breast Cancer Aid
Community Need Drives Event Extension October in Jonesboro just got a bit more hopeful for breast cancer survivors—it's not just about awareness anymore; it's about action. The United Breast Cancer Foundation (UBCF) has decided to extend its popular Pink Bag free shopping event through October 30th. What spurred this decision? Well, the overwhelming community demand,...
Continue Reading
AI Tool circMAC Enhances MicroRNA Mapping on circRNAs
Mapping the Complex Maze of MicroRNA on Circular RNAs Pusan National University's brainiacs have cooked up something spicy for the bioinformatics world. They've developed this snazzy AI tool, circMAC, to unravel microRNA binding mysteries on circular RNAs. 'Why’s this such a big deal?' you ask. Well, these loop-shaped critters, circRNAs, play a backstage role in gene...
Continue Reading
Podium Surges Past $150M in AI ARR Milestone
A New Era for Podium When the brass at Podium made a gamble on AI, they didn't just try squeezing it into their old business model. Oh no, they launched what feels like a startup within their existing empire—no half-measures, just full-throttle ambition. Fast forward two and a half years, and they've racked up over $150 million in annual recurring revenue from these...
Continue Reading
Labcorp, FDA Collaborate to Tackle Drug Abuse Risks
Rethinking How We Evaluate Drug Abuse Potential Sometimes, the finance world gets a peek into something that ain't just about the numbers on a screen, something with real stakes beyond the bulls and bears. Labcorp's just thrown its hat in with the FDA and Charles River Laboratories in a collaboration that goes beyond just lining pockets. They're setting up to dissect how...
Continue Reading
Vertice P2P Aims to Transform Procurement Efficiency
Vertice Dives Deeper into the Procurement Game Grab a coffee and let's talk some procurement—one of the least sexy, yet utterly essential parts of any operation. Vertice's latest announcement is anything but mundane. They're spiraling deeper into the procurement universe with their new Procure-to-Pay (P2P) capability, a bold expansion from their Intake-to-Procure (I2P)...
Continue Reading
Cognizant AI Nexus Aims to Tame Enterprise AI Chaos
AI Investments Without Returns: The Current Scenario Well, wouldn't you know it? Enterprises have sunk a fortune into AI, and they're wagging their fingers once more at the mounting bills with little to show for it. Play the investment game long enough, and it seems you'll find the numbers don't always rub together and make sparks. This familiar tune of over-budget...
Continue Reading
TransPerfect Launches College Bowl Game in Puerto Rico
Puerto Rico Welcomes College Football with Open Arms Imagine kicking towards the goalposts while the ocean breeze kisses your face—yep, that's what's happening in Puerto Rico this December. TransPerfect, a heavyweight in language and tech solutions, is rolling out the red carpet for the inaugural TransPerfect San Juan Bowl, and it’s not just a game. It’s a bold step...
Continue Reading
Carrier Drops $600M on U.S. Manufacturing Boost
A Mighty Move in Manufacturing Carrier Global Corporation's recent muscle-flexing is something rarer than a golden goose in today's market—a $600 million thrust into beefing up U.S. manufacturing and engineering. You can't help but wonder if this is overzealous optimism or a meticulously calculated power play. Clocks don't tick this loudly without good reason, of...
Continue Reading
Innventure Investors Alert: Securities Investigation Looms
Innventure's Murky Waters Just when you think you've seen it all, stuff like this reminds you nothing's safe in the market. The law folks at Stranch, Jennings & Garvey, PLLC are sniffing around Innventure, Inc. (NASDAQ: INV) like bloodhounds to see if there's been some hoodwinking going on. We're talking questions about funny business with a data center deal between...
Continue Reading
Xona's $250M Raise: GPS Transformation Sparks Debate
The Satellite Race Heats Up: Xona's Ambitious Leap Hold onto your hats, folks, because Xona's making headlines with a $250 million infusion. This ain't just pocket change—it's part of a rocket-fueled mission to upend the GPS landscape. Imagine a world where GPS is 100 times stronger. That's the pitch, and folks, it's got the market buzzing. Valuation Rocketing: Investor...
Continue ReadingTop 5 Most Recently Viewed Articles
osapiens Attracts $100 Million Investment, Solidifying Unicorn Status
osapiens Secures Major Funding Round osapiens, a leading firm in enterprise software dedicated to encouraging sustainable growth, has recently announced a significant financial milestone. The company has secured an impressive US$ 100 million in a Series C funding round, spearheaded by Decarbonization Partners, a collaboration between BlackRock and Temasek. This newfound...
Continue Reading
Microsoft Teams Partners with Thrive Global for Enhanced Wellbeing
Microsoft and Thrive Global Join Forces for Employee Wellbeing Microsoft has embarked on an inspiring journey by partnering with Thrive Global, a company that specializes in behavior change strategies aimed at enhancing overall wellbeing. This collaboration aims to integrate a range of wellbeing resources seamlessly into the daily operations of Microsoft Teams, making it...
Continue Reading
Coventry First Challenges Abacus Lawsuit Over Life Settlements
Coventry First LLC Files Motion to Dismiss Lawsuit Coventry First LLC, along with Co-Founder and Executive Chairman Alan H. Buerger, is taking a decisive stand against the lawsuit filed by Abacus Global Management, Inc. This move comes in response to a claim that Coventry believes lacks merit, particularly in light of recent industry changes. Key Developments Around the...
Continue Reading
AbbVie Announces Significant Dividend Increase for Shareholders
AbbVie Declares Quarterly Dividend The board of directors at AbbVie Inc. (NYSE: ABBV) has announced a quarterly cash dividend of $1.55 per share. This decision reflects the company's ongoing commitment to providing value to its shareholders through dependable and substantial dividend distributions. Details and Timeline for the Dividend The announced dividend will be paid...
Continue Reading
GitLab's 'Ultimate' Strategy Drives Adoption and Stock Upgrades
GitLab's Growing Demand for 'Ultimate' GitLab Inc (NASDAQ: GTLB) has recently experienced a notable uptick in the adoption of its 'Ultimate' offering, according to industry expert insights. The stock saw a boost when analyst Mike Cikos from Needham raised its rating from Hold to Buy, setting a price target of $70. This optimistic outlook is backed by GitLab's continued...
Continue Reading